Background and Purpose-There is a lack of modern-day data quantifying the effect of transient ischemic attack (TIA) on survival, and recent data do not take into account expected survival. Methods-Data for 22 157 adults hospitalized with a TIA from July 1, 2000, to June 30, 2007, in New South Wales, Australia, were linked with registered deaths to June 30, 2009. We estimated survival relative to the age-and sex-matched general population up to 9-years after hospitalization for TIA comparing relative risk of excess death between selected subgroups. Results-At 1 year, 91.5% of hospitalized patients with TIA survived compared with 95.0% expected survival in the general population. After 5 years, observed survival was 13.2% lower than expected in relative terms. By 9 years, observed survival was 20% lower than expected. Females had higher relative survival than males (relative risk, 0.79; 95% CI, 0.69 -0.90; PϽ0.001). Increasing age was associated with an increasing risk of excess death compared with the age-matched population. Prior hospitalization for stroke (relative risk, 2.63; 95% CI, 1.98 -3.49) but not TIA (relative risk, 1.42; 95% CI, 0.86 -2.35) significantly increased the risk of excess death. Of all risk factors assessed, congestive heart failure, atrial fibrillation, and prior hospitalization for stroke most strongly impacted survival. Conclusions-This study is the first to quantify the long-term effect of hospitalized TIA on relative survival according to age, sex, and medical history. TIA reduces survival by 4% in the first year and by 20% within 9 years. TIA has a minimal effect on mortality in patients Ͻ50 years but heralds significant reduction in life expectancy in those Ͼ65 years.
T ransient ischemic attack (TIA) is a recognized predictor of early stroke risk and its stroke outcomes have attracted intense interest. Early stroke rates vary 1, 2 and recent studies report low early stroke risk with modern urgent TIA care. [3] [4] [5] [6] In contrast to the emphasis on early stroke risk, detailed analyses of survival after TIA, and how survival varies by age, sex, and medical history have rarely been reported. Multicenter or population-based reports suggest that between 5% and 8% of patients will die within 6 months of their TIA, 7, 8 and others report 5% to 15% dying by 1 year. 3,9 -11 However, the significance of these findings is uncertain. Given the advanced age at which TIA commonly occurs, it is unclear whether the observed mortality exceeds otherwise expected mortality.
Calculating relative survival accounts for the "background risk" of death and identifies the excess risk of mortality above and beyond that expected from the age-and sex-matched general population. Previous population-based or multicenter studies reporting relative survival are only of historic interest with cohorts recruited from 1950 to 1988. [11] [12] [13] [14] [15] [16] These studies are small-scale in terms of geographical scope and sample size (79 -330 participants), further limiting relevance to modern practice. Comparing observed and expected survival establishes the true impact of TIA on mortality, informing health service planning and bedside decision-making such as intensity of investigation, secondary prevention, and follow-up strategies.
In Australia, there are no population-based studies on the impact of TIA on long-term survival. As part of the PRISM study, a Program of Research Informing Stroke Management, we describe relative survival for patients up to 9 years after hospitalization for TIA. We present data on TIA admissions to all hospitals within the state of New South Wales (NSW), the most populous Australian state (estimated population approximately 7 million), 18 from 2000 to 2007 with a minimum 2-year follow-up for fact of death. We aimed to determine variations in relative survival according to age, sex, year of admission, and medical history.
Methods

Databases and Patient Selection
All patients Ͼ18 years of age with a primary diagnosis of TIA (International Classification of Diseases, 10th Revision, Australian Modification [ICD-10-AM] G45.x, 19 excluding G45.4) recorded during a hospital admission between July 1, 2000, to June 30, 2007 , were identified from the Admitted Patient Data Collection. The database is a census of all hospitalizations within NSW, 20 recording the primary reason for hospitalization and up to 54 other diagnoses using standardized ICD-10-AM coding carried out by trained clinical coders. We selected the patient's first recorded primary diagnosis of TIA during the study period. To maximize follow-up, we excluded non-NSW residents and those transferred outside NSW during their hospital stay. Linkage to all prior hospitalizations provided information on medical history leading up to the TIA admission. Fact of death up to June 30, 2009 , was obtained from The NSW Registry of Birth, Deaths and Marriages, a compulsory death registry.
We identified and excluded potential mimic disorders based on an Australian validation study of TIA hospital coding, which identified recognized diagnoses mistaken for TIA at presentation, including stroke, epilepsy and convulsions, migraine, traumatic brain injury, primary and secondary cerebral malignancies, syncope and collapse, toxic-metabolic disturbances, neurodegenerative conditions, and sepsis, including central nervous system infections. 21 We expected approximately 12% of identified patients with TIA to be misclassified cases. 21 Patients with a prior hospitalization for stroke were not excluded.
Data linkage was performed centrally by a government and university-sponsored organization carrying out deidentified data linkage of routinely collected administrative data. 20 
Statistical Analysis
Relative Survival
Relative survival is the ratio of observed survival in the patient population to expected survival estimated from the age-and sexmatched general population (see http://stroke.ahajournals.org, Supplemental Table I for further details). Ratios below the null value (ie, 1 or 100%) indicate "excess mortality" in the patient population relative to the expected mortality. We obtained available life tables 18 corresponding or closely matching the years during our study period to estimate expected survival from the general population of NSW. Observed mortality with TIA was matched to expected rates in the general population according to single year of age and sex with year of discharge used to match patients by age to the general population. Time to death was calculated from the date a TIA diagnosis was first recorded. We used the Ederer II method to compute relative survival estimates. 22 Relative survival was calculated for patients with a TIA diagnosis from July 1, 2000, to June 30, 2007 . Follow-up was for 2 to 9 years. We estimated the relative risk of excess death computing relative risk ratios to test differences in relative survival between sex and age subgroups. Poisson regression models were fitted to grouped data using exact survival times. 22 All models included age (5-year groups), sex, year of discharge, and follow-up interval to control for these effects. Interaction terms between age and sex and age or sex by year of discharge were tested.
Relative Survival and Prior Hospitalization for Cerebrovascular Events
We restricted these analyses to patients with TIA between July 1, 2005, and June 30, 2007 (providing 2 to 4 years of follow-up death data) and identified prior hospitalization for TIA and/or stroke (ICD-10-AM I60.x-I64.x; I69.x) during the previous 5-years. This 5-year "look-back" strategy was reported to remove up to 97% of prior stroke cases in an Australian administrative data set 23 and maximizes our ascertainment of prior stroke.
Relative Risk of Excess Death by Medical History, Including Prior Stroke and TIA
We sought to determine excess mortality attributable to a history of stroke or TIA and risk factors, including congestive heart failure, ischemic heart disease, atrial fibrillation, smoking, hyperlipidemia, diabetes, hypertension, and carotid stenosis. We again restricted analyses to admissions between July 1, 2005, and June 30, 2007, to maximize comorbidity ascertainment with a 5-year "look-back" through hospital diagnoses recorded during and before the TIA admission.
We calculated the relative risk of excess death attributable to each risk factor using Poisson regression models fitted to grouped data using exact survival times 22 controlling for age (5-year age groups), sex, year of discharge, follow-up interval, 22 and all other selected risk factors to produce adjusted estimates of excess mortality (Supplemental Table I for further details). We tested interaction terms to determine whether the effect of medical history on relative survival was modified by patient age and sex. We report these interactions only if statistically significant.
For all Poisson regression models, we tested for the proportionality of relative risk estimates over time by adding an interaction term between follow-up interval and the risk factor of interest (ie, sex, age, or risk factor).
Results
Demographics
Between July 1, 2000, and June 30, 2007, 22,157 eligible TIA admissions were identified. We excluded patients with an unlikely age (Ͼ105 years, Nϭ1), those admitted prior to our study period (Nϭ3), nonresidents of NSW (Nϭ554 [2.1%]) or those transferred outside the state for treatment (Nϭ74 [0.3%]). We also excluded patients identified as having a stroke (Nϭ2036 [7. 6%]) or a TIA mimic (Nϭ1818 [6.8%]) during the TIA admission.
Patients were followed for a median of 4.1 years (interquartile range, 2.6 -6.2). Overall, 23.9% (Nϭ5300) were aged Ͻ65 years of age and 19.4% (Nϭ4309) were Ն85 years. Female patients (50.9%) had a median age of 78 years (interquartile range, 68 -85); male patients (49.1%) were younger (median age, 73 years; interquartile range, 63-80).
Relative Survival
Within 1 year, 91.5% of patients diagnosed with TIA in hospital survived. By comparison, the expected 1-year survival was 95.0%, a 3.8% (ie, 100 minus 96.2%) relative decrease in survival and a relative survival ratio of 96.2%. Within 5 years, 67.2% were still alive compared with an expected survival of 77.4%, a relative survival ratio of 86.8%. A TIA diagnosis resulted in a 13.2% relative decrease in survival by 5 years after TIA. At 9 years, survival was 18.4 lower than expected ( Figure 1 ). Sensitivity analyses demonstrated minimal effects of exclusions on relative survival estimates (Supplemental Table II) .
Relative Survival by Age at Discharge
Relative survival decreased with increasing age. In patients diagnosed with TIA aged 18 to 49 years of age, relative survival was 99.4% at 1 year and 97.5% at 5 years; by 9 years, relative survival decreased minimally to 97.0%. In patients aged 50 to 64 years of age, relative survival estimates at 1, 5, and 9 years, respectively, were 98.6%, 95.6%, and 94.1%. In patients Ͼ65 years, the reduction in relative survival was greater. For example, relative survival for patients aged 65 to 75 years was 96.9% at 1 year and 88.6% at 5 years ( Figure 2 ; Supplemental Table IV) .
Relative Risk of Excess Death According to Sex and Age
After adjusting for age, sex, year of discharge, and follow-up interval, females had a significantly lower risk of excess death compared with males (relative risk, 0.79; 95% CI, 0.69 -0.90; PϽ0.001). However, the relative risk of excess death by sex was nonproportional over time (Pϭ0.003). At 1 year, the risk of excess death in women was almost half that seen in men (relative risk, 0.58; 95% CI, 0.47-0.71; PϽ0.001). Differences in relative survival were not statistically significant beyond 1 year.
The relative risk of excess death associated with a hospital coded diagnosis of TIA significantly increased with increasing age (PϽ0.001), and this effect remained constant over the follow-up period (P value interaction ϭ0.34) after adjusting for sex, year of discharge, and follow-up interval. Compared with patients Ͻ50 years of age (the referent group), patients aged 50 to 64 years and 65 to 74 years were 1.82 (95% CI, 1.14 -2.89) and 4.74 times (95% CI, 3.07-7.30) more likely to experience excess death relative to the general population, respectively. The relative risk of excess death for patients aged 75 to 84 years and 85ϩ years was 7.77 (95% CI, 5.08 -11.89) and 11.02 (95% CI, 7.08 -17.16) times higher, respectively, compared with the referent group. There was no evidence of an age by sex interaction (Pϭ0.28), indicating that the effect of sex did not differ according to age.
Relative Survival by Stroke and TIA History
There were 6807 eligible cases with a primary hospital diagnosis of TIA between July 1, 2005, and June 30, 2007. Median follow-up was 2.8 years (interquartile range, 2.2-3.4). In the previous 5 years, 11 .1% (756) had been hospitalized for stroke of whom 20.9% (158) also had a previous TIA hospitalization; 5.5% (Nϭ374) had a prior TIA hospitalization without a prior stroke admission. Relative survival was lowest in patients with TIA with a history of stroke ( Figure 3) .
Adjusting for age, sex, year of discharge, and follow-up interval, patients with a prior TIA and no prior stroke had a nonsignificant higher risk of excess death than patients with a "first-ever" TIA hospitalization (relative risk, 1.42; 95% CI, 0.86 -2.35; Pϭ0.17). Patients with a stroke history had 2.63 (95% CI, 1.98 -3.49) times the risk of excess death compared with those without any prior cerebrovascular admission (PϽ0.001). History of stroke had a greater impact with increasing time after TIA admission (P value interaction ϭ0.009). In the year after a TIA, the relative risk of death was 1.64 (95% CI, 1.06-2.55) times higher if patients had a history of stroke than if they did not, peaking at 5.01 (95% CI, 2.70-9.30), 3 years after a TIA.
Relative Survival in Patients According to Stroke Risk Factors
Relative survival was negatively affected by all risk factors examined with the exception of hyperlipidemia (Supplemental Table V) . When controlling for all risk factors, age, sex, year of discharge, and follow-up interval, congestive heart failure was associated with the highest relative risk of excess death (relative risk, 3.3; Table) . Previous stroke and atrial fibrillation were each associated with a 2-fold increased risk of excess death, whereas a history of ischemic heart disease, carotid stenosis, diabetes, or smoking increased risk by 20% to 50% (Table) .
Discussion
The PRISM study is a large modern population-based study of patients with a hospital recorded diagnosis of TIA. To our knowledge, it is the largest study reporting relative survival after TIA, estimating the excess mortality that can be attributed to TIA according to age, sex, and medical history. Previous studies of relative survival are at least 20 years old and are limited by small samples (Nϭ79 -330), whereas other multicenter or population-based studies have reported absolute mortality risk, 3,7-11,24 which does not describe the impact of TIA on mortality.
The PRISM data set is large (nϭϾ20 000), representative, and provides detailed information on relative survival up to 9 years after TIA hospitalization. Few studies report follow-up beyond 1 year, 9,10,24 -26 and these have included relatively few patients (approximately Ͻ1000) and/or have not described differences in mortality rates by sex, age, or comorbidity status 9, 10, 24 or cannot be considered representative, where cohorts were recruited into randomized controlled trials or included minor stroke. [25] [26] [27] Relative survival provides an unbiased estimate of cause-specific mortality risk compared with methods that rely on cause-of-death data. Relative survival quantifies the risk of death attributable to TIA in excess of the expected mortality in the age-and sex-matched general population. Relative survival estimation does not require extensive measurement or adjustment of "competing risks" because all other causes of death are accounted for in the expected survival calculations. 22 Our results indicate that almost 10% of patients with TIA admitted to the hospital die within 1 year and this is in keeping with previous reports. 3,9 -11 Additionally, we found that this absolute mortality rate exceeds expected mortality by 4% in relative terms. By 5 years, Ͼ30% of patients with TIA had died, which is 14% greater, in relative survival terms, than expected. At 9 years, almost 50% of patients with TIA had died, 20% greater than expected in the general population.
To our knowledge, this is the first study to comprehensively quantify the effect of a hospital recorded diagnosis of TIA on life expectancy according to age, sex, and medical history. In patients Ͻ50 years of age, relative survival at 1 year approximated the null value, and by 9 years, the observed survival was only 3% lower than expected. In contrast, a TIA heralds a significantly reduced life expectancy for people Ͼ65 years and the relative survival decreases consistently from this age. Previous studies show greater age is associated with an increased risk of mortality in TIA; however, it was unclear to what extent this observed mortality had been due to greater underlying mortality with increasing age. 7, 8 We have shown that the observed versus expected survival widens with age, suggesting that elderly patients with TIA may have the most to gain from intensive cardiovascular risk management.
The better relative survival observed in younger patients with TIA admitted to the hospital for a TIA may reflect the relatively favorable comorbidity profile in young patients with TIA, more readily treatable causes, or a heightened risk of misclassification. Assessing misclassification is difficult but we have deliberately studied patients with a hospital TIA diagnosis, and these diagnoses have been previously validated and found to be highly accurate. 21 Relative to the general population, females were found to have a significantly lower risk of excess death than males. A recent US study of patients with TIA Ͼ65 years, also using hospitalization data, reported that women were significantly less likely than men to die in the year after a TIA. 3 Our results extend this research by controlling for expected survival and demonstrating a sex difference in relative survival across all ages. Importantly, we found that significant differences between women and men in relative survival were confined to the first year after a TIA hospitalization. Authors of the US study proposed that sex differences may be explained by differences in TIA etiology 3 because large-artery atherosclerosis more commonly causes TIA in men and is associated with a poor prognosis. 28 Alternatively, improved risk management in women in the first year after a TIA hospitalization and/or greater access to health services may account for this finding, although data informing such an interpretation are limited. 29 -31 Another suggestion 3 is that women may be more likely to have benign conditions misclassified as TIA. We deliberately removed confounding diagnoses and if misclassification influenced our results, we would expect the difference to persist beyond 1 year.
Prior stroke was associated with 2 times the risk of excess death, consistent with research identifying stroke history as a poor prognostic indicator. 32 A history of a TIA hospitalization reduced relative survival but had less impact than a history of stroke. History of repeated TIAs may indicate a tendency toward less severe, milder cerebrovascular events, lacunar disease, purely sensory episodes, 33, 34 or benign causes of recurrent symptoms such as migraine and anxiety. Clinicians appear more disposed to admit patients with recurrent TIA symptoms, 34 perhaps anticipating higher stroke risk. Such "heuristic" decision-making may result in the misclassification of benign conditions, with recurring symptoms, as a TIA.
The relative risk of excess death attributable to congestive heart failure exceeded that estimated for prior stroke, whereas atrial fibrillation and prior stroke conferred a similar risk of excess mortality. Of all the selected risk factors, only hypertension and hyperlipidemia did not affect relative risk of excess mortality, whereas ischemic heart disease was associated with the lowest risk of excess death in TIA; these results may reflect an adherence to evidence-based guidelines and availability of effective strategies to manage these conditions. 35 Administrative health data are not collected for research purposes. Although coding accuracy may be questioned, a US study validating ICD-10 coding of TIA reported positive predictive values of between 89% to 98%. 36 ICD-10 TIA diagnoses recorded in Australian administrative data were also found to have a high positive predictive value of approximately 88%, when judged against expert diagnosis, indicating that 12% of coded TIA cases are not truly TIA. 21 We identified 14% of cases as TIA mimics, which were excluded from analysis to improve accuracy.
The reliability of comorbidity coding in Australia appears high, indicating adherence to ICD-10-AM coding standards. An Australian study reported substantial to almost perfect agreement between coders for diagnostic codes. 37 Comorbidities are generally undernumerated in administrative data sets but false-positives are rare (Ͻ0.3%). 38 In a strategy known to improve comorbidity ascertainment in the setting of stroke 24 and other circumstances, 39 we applied a 5-year "look-back" period to capture comorbidities identified in prior hospitalizations. Our resulting comorbidity estimates are generally comparable to other studies using more direct methods to determine medical history: hypertension (59% versus 56% to 65%), 6, 40, 41 atrial fibrillation (21% versus 15% to 26%), 5, 6, 42 stroke history (11% versus 9% to 10%), 6, 40, 42 smoking (17% versus 20%), 40 ischemic heart disease (23% versus 15% to 26%), 6, 40 carotid stenosis (6% versus 10% to 12%), 5, 40 diabetes (21% versus 16%) 40, 41 and TIA (8% versus 10%). 43 Only our reported prevalence of hyperlipidemia (26%) appears lower in comparison to other reports (34% to 60%). 5, 6, 40, 42 Our sample consists of patients thought to have TIA by hospital clinicians, reflecting pragmatic service delivery. There is no gold standard diagnostic test for TIA. Uncertainty of TIA diagnosis and its neurovascular significance is systemic in all TIA studies, not just those reliant on administrative data. 44 Over 25% of patients thought to have TIA in the emergency department are found to have a completed stroke on further assessment and Ͼ25% have a confirmed mimic disorder. 21 We could not reliably distinguish among stroke cases misclassified as TIA, cases progressing to stroke after TIA presentation, or complications of stroke mimicking TIA. To reduce the likelihood of misclassification 21 and to improve specificity, we excluded patients who had a stroke diagnosis or a TIA mimic diagnosis recorded during the TIA admission. Although the exclusion of cases with an early post-TIA stroke diagnosis would overestimate relative survival, excluding diagnoses of stroke made during the TIA admission had a very small effect on estimates according to our sensitivity analysis. Early stroke rates are low in Australia after a TIA (Ͻ3%), even among those treated as outpatients. 4, 5, 41 TIA cases that did not present to the hospital but were later admitted with stroke would not have been included. Omitting these patients would have overestimated survival; however, other researchers have excluded such cases because of difficulties in validating the TIA diagnosis. 43 Our results best apply to patients whose main reason for hospital admission remained a TIA throughout their hospital stay. Australian studies report that approximately 70% of patients with an emergency diagnosis of TIA are admitted to the hospital 4 and, of these, only 50% retain a TIA diagnosis. 21 Our cohort represents those retaining a TIA diagnosis on hospital admission, reducing misclassification. Our results cannot be generalized to people who do not present for medical care, who present only to a primary healthcare physician, or who are discharged from an emergency department. Patients with TIA admitted to the hospital are managed differently from patients discharged from emergency. An Australian study has shown that patients with TIA discharged from emergency have fewer stroke risk factors, shorter symptom duration, and higher early stroke risk. 41 Discharged patients probably have higher rates of misclassification than our cohort of patients with TIA, in which the diagnosis was confirmed by hospital investigation.
Administrative data rely on the accuracy of physician diagnoses, which may vary according to the specialty of the treating physician and potentially introduce misclassification. As an example, the identification of mimic disorders depended on physician identification and not all mimics may have been identified and excluded.
We did not have data on treatment likely to influence TIA outcomes; however, this modern cohort of admitted patients is expected to have received urgent hospital treatment shown to reduce early stroke in an Australian setting 4,41 and our results therefore reflect the mortality of treated patients with TIA.
Conclusions
PRISM is the first large TIA study using relative survival to comprehensively quantify the impact of hospital diagnosed TIA on life expectancy according to age, sex, and medical history. Relative survival, the ratio of observed versus expected mortality, is a useful epidemiological tool accounting for competing causes of death without the need to measure these competing causes.
Analyzing for relative survival, we found that a hospital diagnosis of TIA reduced survival by approximately 4% in relative terms in the first year after TIA and that men had a significantly lower relative survival in the first but not subsequent years. A progressively lower relative survival seen with increasing age, Ͼ65 years, suggests that the greatest benefits of secondary prevention may be realized in the elderly.
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Supplemental Table I. Supplemental Methods: Relative survival methods
Relative survival compares observed to expected survival and provides an estimate of "cause-specific" survival, or its corollary, "cause-specific mortality". Observed survival in TIA patients is calculated by identifying the proportion of TIA patients alive at x-years of followup. TIA patient deaths will include deaths due to causes related to having had a TIA and other causes. The expected survival is an estimate of survival in the general population and is an estimate of all causes of death other than those arising from having had a TIA. Relative survival is calculated as a ratio of observed to expected survival, producing an estimate of mortality (ie 1-relative survival ratio) in excess to that which would have otherwise been expected in the general population. In this way, other causes of death, or competing causes, are accounted for in the analysis.
Matching by age and sex ensures that the final relative survival estimates are not affected by differences in the age and sex distribution between the patient sample and the general population. For example, when calculating the relative survival of a male, aged 65, population life-tables provide an estimate of the expected survival for men aged 65. The observed survival of 65 year old males hospitalised for a TIA is therefore compared to the expected survival of 65 year old males. Relative survival therefore, provides a method for estimated excess mortality due to a TIA history.
We calculated relative risk of excess mortality ratios. This analysis compares the relative survival (or mortality) of patients with TIA and the risk factor in question, for example, hypertension, with the relative survival of TIA patients without hypertension. In each case, the relative survival is calculated for these sub-groups, based on the presence or absence of a risk factor, by comparing the observed survival to that which would have been expected from the general population (age and sex-matched). The relative risk of excess mortality ratios, therefore, quantify the differences in relative survival between sub-groups and enable testing of their significance, whilst controlling for other variables entered into the model (eg sex, age, other risk factors, year of discharge). A ratio in excess of 1 (ie the null value), indicates increased excess mortality in one sub-group versus another defined as the "referent" group. As is standard in relative survival analysis, we also controlled for follow-up interval (ie, year 1, 2, 3 etc… ) to account for variability in case distribution and mortality over time. 
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